Larvol Delta - Allyx-Therapeutics-to-Present-Phase-1-Data-for-Lead-Compound-ALX001-at-the-16th-Clinical-Trials-on-Alzheimer39s-Disease-Meeting

ALX-001 - Allyx Therap

https://finance.yahoo.com/news/allyx-therapeutics-present-phase-1-200500420.html

Adam Mecca; Stephen Strittmatter

Oct 20, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next